Zydus Cadila’s formulations manufacturing facility at the Pharma SEZ at Ahmedabad has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) signifying the successful closure of the Audit. The manufacturing plant had completed the USFDA Audit from 16 to 24 January 2017.
Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.